Braun Stacey Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-6,055
| Closed | -$479K | – | 157 |
|
|
2016
Q3 | $479K | Sell |
6,055
-42,592
| -88% | -$3.37M | 0.03% | 128 |
|
|
2016
Q2 | $4.06M | Sell |
48,647
-6,680
| -12% | -$557K | 0.26% | 104 |
|
|
2016
Q1 | $5.08M | Buy |
55,327
+4,170
| +8% | +$383K | 0.33% | 98 |
|
|
2015
Q4 | $5.18M | Buy |
51,157
+44,380
| +655% | +$4.49M | 0.33% | 96 |
|
|
2015
Q3 | $665K | Sell |
6,777
-3,893
| -36% | -$382K | 0.04% | 114 |
|
|
2015
Q2 | $1.25M | Buy |
10,670
+6,805
| +176% | +$797K | 0.05% | 183 |
|
|
2015
Q1 | $379K | Sell |
3,865
-8,170
| -68% | -$801K | 0.02% | 129 |
|
|
2014
Q4 | $1.13M | Buy |
12,035
+6,110
| +103% | +$576K | 0.07% | 111 |
|
|
2014
Q3 | $631K | Buy |
5,925
+3,075
| +108% | +$327K | 0.04% | 117 |
|
|
2014
Q2 | $236K | Buy |
+2,850
| New | +$236K | 0.01% | 151 |
|